Viedoc
Sverre Bengtsson has extensive work experience in the clinical research industry. Sverre co-founded Viedoc in 2003 and served as Co-Founder, Owner, and Sr VP Strategic Relations. Viedoc is a globally acclaimed eClinical Suite used in over 5,000 trials worldwide. Sverre also worked as a Board member and member of the Investment Committee at LSI Alpha starting from December 2020. From May 2020, they have been advising the Board at Pilloxa. Sverre played a crucial role as a Co-Founder and Board Member at ASCRO, an association of CROs active in Sweden, between 2010 and 2014. Additionally, they served as the Managing Director at Clinical Data Care from 1995 to 2003 and worked in the same role at Clinical Data Care in Lund AB. Prior to that, they worked as a Statistician at Cityuniversitetet. Sverre started their career in 1992 as a Business Development professional at MiniDoc.
Sverre Bengtsson's education history begins in 1982 when they attended Sigrid Rudebecks Gymnasium. However, the specific degree and field of study during this period are not specified. From 1987 to 1991, they pursued a Bachelor of Science degree in Business and Economics at the University of Gothenburg. Sverre then went on to enroll at Uppsala University from 1991 to 1993, where they completed their Master of Science degree in Statistics, Mathematics, and Programming. Finally, from 1987 to 2001, Sverre was involved with Studentmusiken, although no degree or field of study is mentioned for this period.
Viedoc
Viedoc design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster.We believe in life and science, in people, and in our collective power to change the world and build a healthier future. That unmatched driving force is what pushes us to innovate, accelerate and improve everyaspect of modern clinical studies. Since 2003, Viedoc has united scientists and clinical trial professionals in a shared mission of pushing life-changing research forward. Our solution has been used to power thousands of studies, by collecting data from over a million patients and allowing it to flow smoothly across sites and countries. We take great pride in helping bridge the gap between patient and researcher – and, in the best of cases, between research and breakthrough.